decoration

Poids de l’Open access dans la production CNRS

Titre
Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial
BSO - Titre
Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial
DOI
DOAI
Identifiant WoS
WOS:000399551700025
Accès ouvert
OA - Non
Source - Accès ouvert
OA - Non
Type d'accès
Non OA
Editeur

Elsevier

Source

LANCET DIABETES & ENDOCRINOLOGY

ISSN
2213-8587
Type de document
  • Article
Notoriété
5 - Exceptionnelle
CNRS
Oui
CNRS - Institut
  • INSB - Institut des sciences biologiques
uid:/5TBJ36F7
Powered by Lodex 9.6.0
decoration